Trivalent Gd-DOTA reagents for modification of proteins† †Electronic supplementary information (ESI) available: Synthetic details for known compounds; materials and methods for bioconjugation reactions; copies of spectra of new compounds and compounds prepared according to new procedures. See DOI: 10.1039/c5ra20359g Click here for additional data file.
The development of novel protein-targeted MRI contrast agents crucially depends on the ability to derivatise suitable targeting moieties with a high payload of relaxation enhancer without losing affinity for the target proteins.
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Royal Society of Chemistry
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4786947/ |